지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2010.4
- 수록면
- 219 - 224 (6page)
이용수
초록· 키워드
오류제보하기
Purpose: This study was performed to evaluate clinicopathologic features in anal canal carcinoma.
Methods: Among the 43 patients who were diagnosed with anal cancer at Kangnam St. Mary’s Hospital, from June 1990 to June 2008, 31 patients were analyzed retrospectively. Concurrent chemoradiotherapy was performed on twenty-one patients with anal cancer. Chemotherapy with 5-FU/mitomycin and radiotherapy were started at the same time. An external beam radiation dose to the primary lesion and pelvis was modified from 4,500 to 6,000 cGy.
Results: Among the 31 patients with anal cancer, the dominant histologic type was squamous cell carcinoma (n=25), followed by adenocarcinoma (n=6). Twenty-nine (93.5%) of these cancers were located in the anal canal and 2 (6.5%) in the anal margin. Among the 25 patients with squamous cell carcinoma, 20 cases were treated by concurrent chemoradiotherapy. The 5-year survival rate among squamous cell carcinoma cases was 83.3% for the concurrent chemoradiation group and 50.0% for the no concurrent chemoradiation group, which was statistically significant (P=0.05). Among the squamous cell carcinoma patients, there was no significant difference in survival rates between concurrent chemoradiation group (n=17) and concurrent chemoradiation with surgical resection group (n=8) (87.5% vs 68.8%; P=0.596).
Conclusion: In the squamous cell carcinoma treatment, concurrent chemoradiation therapy can offer better outcomes.
Methods: Among the 43 patients who were diagnosed with anal cancer at Kangnam St. Mary’s Hospital, from June 1990 to June 2008, 31 patients were analyzed retrospectively. Concurrent chemoradiotherapy was performed on twenty-one patients with anal cancer. Chemotherapy with 5-FU/mitomycin and radiotherapy were started at the same time. An external beam radiation dose to the primary lesion and pelvis was modified from 4,500 to 6,000 cGy.
Results: Among the 31 patients with anal cancer, the dominant histologic type was squamous cell carcinoma (n=25), followed by adenocarcinoma (n=6). Twenty-nine (93.5%) of these cancers were located in the anal canal and 2 (6.5%) in the anal margin. Among the 25 patients with squamous cell carcinoma, 20 cases were treated by concurrent chemoradiotherapy. The 5-year survival rate among squamous cell carcinoma cases was 83.3% for the concurrent chemoradiation group and 50.0% for the no concurrent chemoradiation group, which was statistically significant (P=0.05). Among the squamous cell carcinoma patients, there was no significant difference in survival rates between concurrent chemoradiation group (n=17) and concurrent chemoradiation with surgical resection group (n=8) (87.5% vs 68.8%; P=0.596).
Conclusion: In the squamous cell carcinoma treatment, concurrent chemoradiation therapy can offer better outcomes.
목차
서론
방법
결과
고찰
결론
REFERENCES
참고문헌 (23)
참고문헌 신청
1. [학술지(정기간행물)] - Nigro ND / 1974 / Combined therapy for cancer of the anal canal: a preliminary report / Dis Colon Rectum 17 : 354 ~ 356
2. [학술지(정기간행물)] - Whiteford MH / 2001 / The evolving treatment of anal cancer: how are we doing? / Arch Surg 136 : 886 ~ 891
3. [보고서] - Ministry for Health, Welfare and Family Affairs / 2008 / Annual Report of Cancer Incidence (2003) in Korea
4. [학술지(정기간행물)] - Deans GT / 1994 / Malignant anal tumours / Br J Surg 81 : 500 ~ 508
5. [학술지(정기간행물)] - Adam YG / 1987 / Current concepts and controversies concerning the etiology, pathogenesis, diagnosis, and treatment of malignant tumors of the anus / Surgery 101 : 253 ~ 266
2. [학술지(정기간행물)] - Whiteford MH / 2001 / The evolving treatment of anal cancer: how are we doing? / Arch Surg 136 : 886 ~ 891
3. [보고서] - Ministry for Health, Welfare and Family Affairs / 2008 / Annual Report of Cancer Incidence (2003) in Korea
4. [학술지(정기간행물)] - Deans GT / 1994 / Malignant anal tumours / Br J Surg 81 : 500 ~ 508
5. [학술지(정기간행물)] - Adam YG / 1987 / Current concepts and controversies concerning the etiology, pathogenesis, diagnosis, and treatment of malignant tumors of the anus / Surgery 101 : 253 ~ 266
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
국소진행성 비소세포폐암에서 Paclitaxel 매주투여 및 방사선치료 동시요법
Tuberculosis and Respiratory Diseases
2004 .01
-
Salvage Resection after Localized Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma
한국간담췌외과학회 학술대회지
2012 .04
-
항문관 표피양 암종의 비수술적 화학방사선 병합요법의 임상적 고찰
Annals of Surgical Treatment and Research
2001 .10
-
Comparison of the Result of Radiation Alone and Chemoradiation in Cervical Cancer
Radiation oncology journal : ROJ
1995 .01
-
항문암의 동시 화학 방사선 요법 치료결과
Radiation oncology journal : ROJ
1994 .01
-
[Poster] The long-term outcomes in patients who underwent chemoradiation for anal cancer
대한외과학회 학술대회 초록집
2011 .11
-
비인강암의 치료 성적 및 예후 인자
대한이비인후-두경부외과학회지
2016 .01
-
Concurrent Chemoradiation Therapy in Stage III Non-small Cell Lung Cancer
Radiation oncology journal : ROJ
1997 .01
-
Long-Term Outcomes of Chemoradiation for Anal Cancer Patients
Yonsei Medical Journal
2013 .01
-
수술이 불가능한 식도암에서 동시 항암화학방사선요법의효과
대한내과학회지
2007 .01
-
식도암에서의 동시화학방사선요법
Radiation oncology journal : ROJ
1998 .01
-
Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Oncologic outcomes of squamous cell carcinoma of the anal canal after chemoradiation therapy
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2016 .06
-
Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer
Cancer Research and Treatment
2011 .01
-
국소적으로 진행된 두경부 편평상피세포종양의 방사선- 항암화학 병용요법과 방사선단독치료의 비교
Radiation oncology journal : ROJ
1996 .01
-
Current and Future Direction of Chemoradiation Therapy on Head and Neck Cancer
대한두경부종양학회 학술대회
2005 .01
-
국소적으로 진행된 자궁경부암에서 방사선 단독치료와 방사선 및 저용량 Cisplatin 항암화학요법 병용치료의 비교
Radiation oncology journal : ROJ
2004 .01
-
절제 불가능한 췌장암의 동시항암화학방사선요법
Radiation oncology journal : ROJ
2002 .01
-
직장암에서 술전 방사선-화학 요법의 효과
Annals of Surgical Treatment and Research
1997 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2013-514-002679445